GlassScriptPhysician profile
Mai T Dinh
NPI 1811277569
$2,672.55
in general payments reported to CMS, 2019-2025
16 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $656 · 2020: $130 · 2021: $278 · 2022: $590 · 2023: $418 · 2024: $383 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,003 · Entertainment: $16.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,002.61 |
| Entertainment | $16.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $804.74 | 2019-2023 | Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $528.00 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $509.28 | 2019-2024 | Precision 1, Total30 |
| Abbvie INC. | $232.18 | 2022-2024 | Vuity |
| Tarsus Pharmaceuticals, INC. | $163.30 | 2024-2025 | Xdemvy |
| Astellas Pharma US INC | $124.90 | 2024 | Izervay |
| Allergan, INC. | $67.18 | 2022 | |
| Abb Con-Cise Optical Group LLC | $63.89 | 2019-2022 | |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $33.20 | 2019 | |
| Biotissue Holdings INC. | $24.97 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $21.27 | 2022 | |
| Novo Nordisk INC | $17.05 | 2023 | Rybelsus |
| Optos, INC. | $16.06 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb Americas INC. | $14.35 | 2025 | Miebo, Xiidra |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyevance Pharmaceuticals LLC | $13.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mai Dinh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.